瑞普利蒙生物 REPL
$21.62 +$1.60 (+7.99%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $21.61 -0.05%
开盘$20.20
昨收$20.02
当日区间$20.20 – $21.91
成交量2.98M
市值$2.05B
市盈率（TTM）–
股息率–
REPL 相关新闻
匹配 Replimune 或代码 REPL 的头条新闻，按最新排序。
- Sri Trang Gloves: REPL-General Announcement-Reporting Share Repurchase form for Financial Management Purposes No.2 (Revised Date)
- BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $20
- Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $19 正面
- Piper Sandler Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14
- BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20 正面
- Leerink Partners Initiates Replimune(REPL.US) With Buy Rating, Announces Target Price $17
- Frasers Property: REPL-General Announcement-Issue of S$150 Million Fixed Rate Notes Due 2036 By Frasers Property Treasury Pte. Ltd.
- J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $21 正面
- Jefferies Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $24 正面
- Wedbush Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $19
- J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20 正面
- Cantor Fitzgerald Upgrades Replimune(REPL.US) to Buy Rating 正面
- Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $12 正面
- BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $16
- Wedbush Downgrades Replimune(REPL.US) to Hold Rating, Cuts Target Price to $9 负面
暂无评论——快来第一个聊聊 REPL。
登录后参与讨论。